Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W3BE
|
|||
Drug Name |
Pyrrolo[2,3-d]pyrimidine derivative 31
|
|||
Synonyms |
PMID28705083-Compound-29
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
BIOGEN MA INC. SUNESIS PHARMACEUTICALS, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C33H34N6O3S
|
|||
Canonical SMILES |
CC1=C(C=CC(=C1)C2=C3C=C(NC3=NC=N2)C4=CC=C(C=C4)C(=O)N5CCOCC5)CNC(=O)C6=NC=C(S6)C(C)(C)C
|
|||
InChI |
1S/C33H34N6O3S/c1-20-15-23(9-10-24(20)17-34-30(40)31-35-18-27(43-31)33(2,3)4)28-25-16-26(38-29(25)37-19-36-28)21-5-7-22(8-6-21)32(41)39-11-13-42-14-12-39/h5-10,15-16,18-19H,11-14,17H2,1-4H3,(H,34,40)(H,36,37,38)
|
|||
InChIKey |
HVNCDYSVQHLXPA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.Expert Opin Ther Pat. 2017 Dec;27(12):1305-1318. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.